Alembic Pharmaceuticals Limited recalls
5 notices naming Alembic Pharmaceuticals Limited as the recalling firm, since June 4, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Alembic Pharmaceuticals Limited: Fesoterodine Fumarate
Hazard (FDA): Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
FDAMedicines
Alembic Pharmaceuticals Limited: Fesoterodine Fumarate
Hazard (FDA): Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
FDAMedicines
Alembic Pharmaceuticals Limited: Doxepin Hydrochloride Capsules
Hazard (FDA): CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
FDAMedicines
Alembic Pharmaceuticals Limited: Celecoxib Capsules
Hazard (FDA): Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule
FDAMedicines
Alembic Pharmaceuticals Limited: Bromfenac Ophthalmic Solution 0.09%
Hazard (FDA): Failed Impurities/Degradation Specifications
FDAMedicines